The laboratory is dedicated to the design of probiotic, pharmacobiotic and phytobiotic products for human and animal health. In human health, specifically to the prevention and treatment of female urogenital tract infections. In projects aimed at animal health, it deals with the effect of native probiotic lactic acid bacteria in the prevention of bovine infections (metritis and mastitis, neonatal diarrhea in calves, steers in intensive fattening systems), pigs, in canine puppies, and in aquaculture (frogs and freshwater fish farming). The mechanisms involved in the protective effect are studied through in vitro tests that include: adhesion to surfaces and mucous membranes, biofilm formation and production of antagonistic substances against pathogens, or exopolysaccharides, among others; In addition, technological properties of the strains are evaluated for an effective transfer to the productive sector. Safety and innocuousness characteristics are studied in experimental host models and specific mucosa. Probiotic lactic acid bacteria are available for different hosts and tracts, which are included and evaluated in formulas for reconstitution of the microbiota and protection against pathogens.

Members       Areas of Research